48
Views
21
CrossRef citations to date
0
Altmetric
Special Report

Nickel: a unique allergen – from molecular structure to European legislation

, &
Pages 851-859 | Published online: 10 Jan 2014

References

  • Nielsen FH. Is nickel nutritionally important? Nutr. Today28, 14–19 (1993).
  • Brown PH, Welch RM, Cary EE. Nickel: a micronutrient essential for higher plants. Plant Physiol.85, 801–803 (1987).
  • Wackett LP, Honek JF, Begley TP et al. Methyl-S-coenzyme-M reductase: a nickel-dependent enzyme catalyzing the terminal redox step in methane biogenesis. In: The Bioinorganic Chemistry of Nickel.Lancaster JR Jr (Ed.).VCH Publishers, NY, USA 249–274 (1988).
  • Ragsdale SW, Wood HG, Morton TA et al. Nickel in CO dehydrogenase. In: The Bioinorganic Chemistry of Nickel.Lancaster JR Jr (Ed.). VCH Publishers, NY, USA 311–332 (1988).
  • Tallant EA, Cheung WY. Calmodulin-dependent protein phosphatase. In: Calcium and Cell Function VI.Cheung WY (Ed.). Academic Press, NY, USA 71–112 (1986).
  • Al-Daraji WI, Grant KR, Ryan K et al. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A. J. Invest. Dermatol.118, 779–788 (2002).
  • Mukai H, Ito A, Kishima K et al. Calmodulin antagonists differentiate between Ni2+- and Mn2+-stimulated phosphatase activity of calcineurin. J. Biochem. (Tokyo)110, 402–406 (1991).
  • Matsui H, Pallen CJ, Adachi AM et al. Demonstration of different metal ion-induced calcineurin conformations using a monoclonal antibody. J. Biol. Chem.260, 4174–4179 (1985).
  • Alomar A, Puig L, Gallardo CM, Valenzuela N. Topical tacrolimus 0.1% ointment (protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema.Contact Derm.49, 185–188 (2003).
  • Belsito D, Wilson DC, Warshaw E et al. A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis. J. Am. Acad. Dermatol.55, 40–46 (2006).
  • Veien NK, Andersen MR. Nickel in Danish food. Acta Derm. Venereol.66, 502–509 (1986).
  • Flyvholm MA, Nielsen GD, Andersen A. Nickel content of food and estimation of dietary intake. Z. Lebensm. Unters. Forsch.179, 427–431 (1984).
  • Proctor NH, Hughes JP, Fischman ML. Chemical Hazards at the Workplace. Lippincott, PA, USA 359–361 (1988).
  • Chen H, Costa M. Effect of soluble nickel on cellular energy metabolism in A549 cells. Exp. Biol. Med. (Maywood)231, 1474–1480 (2006).
  • Salsano F, Francia C, Roumpedaki I et al. Immune effects of nickel. Int. J. Immunopathol. Pharmacol.17(2 Suppl.), 63–69 (2004).
  • Salsano F, Francia C, Proietti AR et al. Impaired natural killer cell activity associates with increased susceptibility to inflammation induced by herpesvirus infection in patients with nickel hypersensitivity. Eur. J. Inflam.3, 143–148 (2005).
  • Chen CY, Wang YF, Lin YH, Yen SF. Nickel-induced oxidative stress and effect of antioxidants in human lymphocytes. Arch. Toxicol.77, 123–130 (2003).
  • Chen CY, Lin TH. Effects of nickel chloride on human platelets: enhancement of lipid peroxidation, inhibition of aggregation and interaction with ascorbic acid. J. Toxicol. Environ. Health A62, 431–438 (2001).
  • Lepoittevin JP, Benezra C. The chemistry of contact allergy – why is a substance allergenic? Rev. Franc. Allergol. Immunol. Clin.31, 235–241 (1991).
  • Barratt MD, Basketter DA. Chemical aspects of contact hypersensitivity. In: Toxicology of Contact Hypersensitivity. Kimber I, Maurer T (Eds). Taylor & Francis, London, UK 75–97 (1996).
  • Roberts DW, Lepoittevin JP. Hapten-protein interactions. In: Allergic Contact Dermatitis. The Molecular Basis. Lepoittevin JP, Basketter DA, Goossens A et al. (Eds). Springer, Berlin, Germany 82–111 (1998).
  • Friedmann PS. Contact sensitization and allergic contact dermatitis: immunobiological mechanisms. Toxicol. Lett.162, 49–54 (2006).
  • Vollmer J, Weltzien HU, Moulon C. TCR reactivity in human nickel allergy indicates contacts with complementarity-determining region 3 but excludes superantigen-like recognition. J. Immunol.163, 2723–2731 (1999).
  • Vollmer J, Weltzien HU, Gamerdinger K et al. Antigen contacts by Ni-reactive TCR: typical αβ chain cooperation versus α chain-dominated specificity. Int. Immunol.12, 1723–1731 (2000).
  • Gamerdinger K, Moulon C, Karp DR et al. A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel. J. Exp. Med.197, 1345–1353 (2003).
  • Toebak MJ, Pohlmann PR, Sampat-Sardjoepersad SC et al. CXCL8 secretion by dendritic cells predicts contact allergens from irritants. Toxicol. In Vitro20, 117–124 (2006).
  • Arrighi JF, Rebsamen M, Rousset F et al. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-α, and contact sensitizers. J. Immunol.166, 3837–3845 (2001).
  • Aiba S, Manome H, Nakagawa S et al. p38 mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and 2,4-dinitrochlorobenzene. J. Invest. Dermatol.120, 390–399 (2003).
  • Boisleve F, Kerdine-Romer S, Rougier-Larzat N et al. Nickel and DNCB induce CCR7 expression on human dendritic cells through different signalling pathways: role of TNF-α and MAPK. J. Invest. Dermatol.123, 494–502 (2004).
  • Moed H, Boorsma DM, Stoof TJ et al. Nickel-responding T cells are CD4+ CLA+ CD45RO+ and express chemokine receptors CXCR3, CCR4 and CCR10. Br. J. Dermatol.151, 32–41 (2004).
  • Dong C, Flavell RA. Cell fate decision: T-helper 1 and 2 subsets in immune responses. Arthritis Res.2, 179–188 (2000).
  • O’Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity8, 275–283 (1998).
  • Mosmann TR, Li L, Sad S. Functions of CD8 T-cell subsets secreting different cytokine patterns. Semin. Immunol.9, 87–92 (1997).
  • Cerwenka A, Carter LL, Reome JB et al.In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J. Immunol.161, 97–105 (1998).
  • Minang JT, Arestrom I, Zuber B et al. Nickel-induced IL-10 down-regulates Th1-but not Th2-type cytokine responses to the contact allergen nickel. Clin. Exp. Immunol.143, 494–502 (2006).
  • Vocanson M, Hennino A, Cluzel-Tailhardat M et al. CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. J. Invest. Dermatol.126(4), 815–820 (2006).
  • Wahlkvist H, Masjedi K, Gruvberger B et al. The lipophilic hapten parthenolide induces IFN-γ and IL-13 production by peripheral blood-derived CD8+ T cells from contact allergic subjects in vitro.Br. J. Dermatol. (In Press) (2007).
  • Jensen CS, Menne T, Lisby S et al. Experimental systemic contact dermatitis from nickel: a dose-response study. Contact Derm.49, 124–132 (2003).
  • Jensen CS, Menne T, Johansen JD. Systemic contact dermatitis after oral exposure to nickel: a review with a modified meta-analysis. Contact Derm.54, 79–86 (2006).
  • Vandenberg JJ, Epstein WL. Experimental nickel contact sensitization in man. J. Invest. Dermatol.41, 413–418 (1963).
  • Fischer LA, Menne T, Johansen JD. Experimental nickel elicitation thresholds – a review focusing on occluded nickel exposure. Contact Derm.52, 57–64 (2005).
  • Genelhu MC, Marigo M, ves-Oliveira LF et al. Characterization of nickel-induced allergic contact stomatitis associated with fixed orthodontic appliances. Am. J. Orthod. Dentofacial Orthop.128, 378–381 (2005).
  • Mancuso G, Berdondini RM. Eyelid dermatitis and conjunctivitis as sole manifestations of allergy to nickel in an orthodontic appliance. Contact Derm.46, 245 (2002).
  • Guerra L, Rogkakou A, Massacane P et al. Role of contact sensitization in chronic urticaria. J. Am. Acad. Dermatol.56, 88–90 (2007).
  • Malo JL, Cartier A, Gagnon G et al. Isolated late asthmatic reaction due to nickel sulphate without antibodies to nickel. Clin. Allergy15, 95–99 (1985).
  • Niordson AM. Nickel sensitivity as a cause of rhinitis. Contact Derm.7, 273–274 (1981).
  • Spiewak R, Brewczynski PZ. Powiklania po stabilizacji plyta metalowa zlamania kosci udowej u chorej z alergia kontaktowa na chrom, nikiel i kobalt. Pol. Tyg. Lek. (Wars)48, 651–652 (1993).
  • Rahilly G, Price N. Nickel allergy and orthodontics. J. Orthod.30, 171–174 (2003).
  • Koster R, Vieluf D, Kiehn M et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet356, 1895–1897 (2000).
  • Lachapelle JM, Maibach HI. Patch Testing and Prick Testing. A Practical Guide. Springer, Berlin, Germany 1–136 (2003).
  • Bruze M, Isaksson M, Edman B et al. A study on expert reading of patch test reactions: inter-individual accordance. Contact Derm.32, 331–337 (1995).
  • van Strien GA, Korstanje MJ. Site variations in patch test responses on the back. Contact Derm.31, 95–96 (1994).
  • Hindsen M, Bruze M, Christensen OB. Individual variation in nickel patch test reactivity. Am. J. Contact Derm.10, 62–67 (1999).
  • Spiewak R. Problems with interpreting the results of allergological patch tests: an analysis of test results in 196 patients with suspected contact dermatitis. Int. Rev. Allergol. Clin. Immunol.3(Suppl. 2), 36 (1997).
  • Aberer W. Die “falsch-positive” Epikutantest-Reaktion. Derm. Beruf Umwelt36, 13–16 (1988).
  • Damian DL, Barnetson RS, Halliday GM. Effects of low-dose ultraviolet radiation on in vivo human cutaneous recall responses. Australas. J. Dermatol.42, 161–167 (2001).
  • Green C. The effect of topically applied corticosteroid on irritant and allergic patch test reactions.Contact Derm.35, 331–333 (1996).
  • Anveden I, Lindberg M, Andersen KE et al. Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel. Contact Derm.50, 298–303 (2004).
  • Mitchell JC. The angry back syndrome: eczema creates eczema. Contact Derm.1, 193–194 (1975).
  • Bruynzeel DP, van Ketel WG, von Blomberg-van der Flier M et al. Angry back or the excited skin syndrome. A prospective study. J. Am. Acad. Dermatol.8, 392–397 (1983).
  • Rocklin RE, Meyers OL, David JR. An in vitro assay for cellular hypersensitivity in man. J. Immunol.104, 95–102 (1970).
  • Geczy AF, Baumgarten A. Lymphocyte transformation in contact sensitivity. Immunology19, 189–203 (1970).
  • Macleod TM, Hutchinson F, Raffle EJ. The uptake of labelled thymidine by leucocytes of nickel sensitive patients. Br. J. Dermatol.82, 487–492 (1970).
  • von Blomberg-vander Flier M, van der Burg CK, Pos O et al. In vitro studies in nickel allergy: diagnostic value of a dual parameter analysis. J. Invest. Dermatol.88, 362–368 (1987).
  • Hallab NJ, Mikecz K, Jacobs JJ. A triple assay technique for the evaluation of metal-induced, delayed-type hypersensitivity responses in patients with or receiving total joint arthroplasty. J. Biomed. Mater. Res.53, 480–489 (2000).
  • Rustemeyer T, von Blomberg BM, van Hoogstraten IM et al. Analysis of effector and regulatory immune reactivity to nickel. Clin. Exp. Allergy34, 1458–1466 (2004).
  • Spiewak R, Moed H, von Blomberg BME et al. Allergic contact dermatitis to nickel: modified in vitro test protocols for better detection of allergen-specific response. Contact Derm.56, 63–69 (2007).
  • Wall LM. Spot tests and chemical analyses for allergen evaluation. In: Textbook of Contact Dermatitis. Rycroft RJ, Menne T, Frosch PJ (Eds). Springer, Berlin, Germany 277–284 (1995).
  • Uter W, Hegewald J, Aberer W et al. The European standard series in 9 European countries, 2002/2003 – first results of the European Surveillance System on Contact Allergies. Contact Derm.53, 136–145 (2005).
  • Spiewak R. Allergische Kontaktdermatitis im Kindesalter. Eine Übersicht und Meta-Analyse. Allergologie25, 374–381 (2002).
  • Schäfer T, Böhler E, Ruhdorfer S et al. Epidemiology of contact allergy in adults. Allergy56, 1192–1196 (2001).
  • Uter W, Pfahlberg A, Gefeller O et al. Risk factors for contact allergy to nickel – results of a multifactorial analysis. Contact Derm.48, 33–38 (2003).
  • Mortz CG, Lauritsen JM, Bindslev-Jensen C et al. Nickel sensitization in adolescents and association with ear piercing, use of dental braces and hand eczema. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis (TOACS). Acta Derm. Venereol.82, 359–364 (2002).
  • Leyden JJ, Kligman AM. Allergic contact dermatitis: sex differences. Contact Derm.3(6), 333–336 (1977).
  • Jensen CS, Lisby S, Baadsgaard O et al. Decrease in nickel sensitization in a Danish schoolgirl population with ears pierced after implementation of a nickel-exposure regulation. Br. J. Dermatol.146, 636–642 (2002).
  • Linneberg A, Nielsen NH, Menne T et al. Smoking might be a risk factor for contact allergy. J. Allergy Clin. Immunol.111, 980–984 (2003).
  • Spiewak R. Atopy and contact hypersensitivity: a reassessment of the relationship using objective measures. Ann. Allergy Asthma Immunol.95, 61–65 (2005).
  • Bryld LE, Hindsberger C, Kyvik KO et al. Risk factors influencing the development of hand eczema in a population-based twin sample. Br. J. Dermatol.149, 1214–1220 (2003).
  • European Parliament and Council Directive 94/27/EC of 30 June 1994 amending for the 12th time Directive 76/769/EEC on the approximation of the laws, regulations and administrative provisions of the Member States relating to restrictions on the marketing and use of certain dangerous substances and preparations. Official Journal L188, 1–2 (1994).
  • European Council Directive of 27 July 1976 on the approximation of the laws, regulations and administrative provisions of the Member States relating to restrictions on the marketing and use of certain dangerous substances and preparations (76/769/EEC). Official Journal L262, 201 (1976).
  • Aberer W, Kränke B. The new EURO releases nickel and elicits contact eczema. Br. J. Dermatol.146, 155–156 (2002).
  • Nestle FO, Speidel H, Speidel MO. Metallurgy: high nickel release from 1- and 2-Euro coins. Nature419, 132 (2002).
  • Foti C, Seidenari S, Antelmi A et al. Provocative use test of 1 Euro coin in nickel-sensitized subjects. Contact Derm.52, 167–168 (2005).
  • European Council Regulation (EC) No 975/98 of 3 May 1998 on denominations and technical specifications of Euro coins intended for circulation. Official Journal L139, 6–8 (1998).
  • Jakobson E, Masjedi K, Ahlborg N et al. Cytokine production in nickel-sensitized individuals analysed with enzyme-linked immunospot assay: possible implication for diagnosis. Br. J. Dermatol.147, 442–449 (2002).
  • Lindemann M, Bohmer J, Zabel M, Grosse-Wilde H. ELISpot: a new tool for the detection of nickel sensitization. Clin. Exp. Allergy33, 992–998 (2003).
  • Minang JT, Troye-Blomberg M, Lundeberg L, Ahlborg N. Nickel elicits concomitant and correlated in vitro production of Th1-, Th2-type and regulatory cytokines in subjects with contact allergy to nickel. Scand. J. Immunol.62, 289–296 (2005).
  • Borg L, Christensen JM, Kristiansen J, Nielsen NH et al. Nickel-induced cytokine production from mononuclear cells in nickel-sensitive individuals and controls. Cytokine profiles in nickel-sensitive individuals with nickel allergy-related hand eczema before and after nickel challenge. Arch. Dermatol. Res.292, 285–291 (2000).
  • Minang JT, Ahlborg N, Troye-Blomberg M. A simplified ELISpot assay protocol used for detection of human interleukin-4, interleukin-13 and interferon-γ production in response to the contact allergen nickel. Exogenous Dermatol.2, 306–313 (2003).
  • Buchvald D, Lundeberg L. Impaired responses of peripheral blood mononuclear cells to nickel in patients with nickel-allergic contact dermatitis and concomitant atopic dermatitis. Br. J. Dermatol.150, 484–492 (2004).

Websites

  • Nickel Institute www.nickelinstitute.org
  • Food Standards Agency. Nickel www.eatwell.gov.uk/healthydiet/nutritionessentials/vitaminsandminerals/nickel/
  • Eurostat. Europe in figures – Eurostat yearbook 2006–07 – Population. KS-CD-06–001–01 http://epp.eurostat.ec.europa.eu/
  • Eurostat. ECHI. Demographic and Socioeconomics factors indicators http://ec.europa.eu/health/ph_information/dissemination/echi/echi_1_en.htm#1

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.